Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Related Citations for PubMed (Select 23336966)

1.

Antimicrobial surveillance in idiopathic parkinsonism: indication-specific improvement in hypokinesia following Helicobacter pylori eradication and non-specific effect of antimicrobials for other indications in worsening rigidity.

Dobbs SM, Charlett A, Dobbs RJ, Weller C, Iguodala O, Smee C, Lawson AJ, Taylor D, Bjarnason I.

Helicobacter. 2013 Jun;18(3):187-96. doi: 10.1111/hel.12035. Epub 2013 Jan 22.

PMID:
23336966
2.

Differential effect of Helicobacter pylori eradication on time-trends in brady/hypokinesia and rigidity in idiopathic parkinsonism.

Dobbs SM, Dobbs RJ, Weller C, Charlett A, Bjarnason IT, Lawson AJ, Letley D, Harbin L, Price AB, Ibrahim MA, Oxlade NL, Bowthorpe J, Leckstroem D, Smee C, Plant JM, Peterson DW.

Helicobacter. 2010 Aug;15(4):279-94. doi: 10.1111/j.1523-5378.2010.00768.x.

3.

Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study.

Dobbs RJ, Charlett A, Dobbs SM, Weller C, A Ibrahim MA, Iguodala O, Smee C, Plant JM, Lawson AJ, Taylor D, Bjarnason I.

Gut Pathog. 2012 Oct 19;4(1):12. doi: 10.1186/1757-4749-4-12.

4.

Significantly higher frequency of Helicobacter suis in patients with idiopathic parkinsonism than in control patients.

Blaecher C, Smet A, Flahou B, Pasmans F, Ducatelle R, Taylor D, Weller C, Bjarnason I, Charlett A, Lawson AJ, Dobbs RJ, Dobbs SM, Haesebrouck F.

Aliment Pharmacol Ther. 2013 Dec;38(11-12):1347-53. doi: 10.1111/apt.12520. Epub 2013 Oct 5.

5.

Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 1: eradication of Helicobacter in the cachexia of idiopathic parkinsonism.

Dobbs RJ, Dobbs SM, Weller C, Bjarnason IT, Oxlade NL, Charlett A, Al-Janabi MA, Kerwin RW, Mahler RF, Price AB.

Helicobacter. 2005 Aug;10(4):267-75. Erratum in: Helicobacter. 2005 Oct;10(5):557. Bjarnason, Ingua T [corrected to Bjarnason, Ingvar T].

PMID:
16104942
6.

Towards defining a rigidity-associated pathogenic pathway in idiopathic parkinsonism.

Dobbs RJ, Charlett A, Dobbs SM, Weller C, Iguodala O, Smee C, Bowthorpe J, Taylor D, Bjarnason IT.

Neurodegener Dis. 2012;10(1-4):183-6. doi: 10.1159/000332807. Epub 2011 Dec 23. Review.

PMID:
22205039
7.

Recurrence of Helicobacter pylori infection after eradication: incidence and variables influencing it.

Gisbert JP, Pajares JM, García-Valriberas R, Abraira V, Boixeda D, García-Grávalos R, Martín-de-Argila C, García-Plaza A.

Scand J Gastroenterol. 1998 Nov;33(11):1144-51.

PMID:
9867091
8.

Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.

Toyokawa T, Suwaki K, Miyake Y, Nakatsu M, Ando M.

J Gastroenterol Hepatol. 2010 Mar;25(3):544-7. doi: 10.1111/j.1440-1746.2009.05995.x. Epub 2009 Oct 6.

PMID:
19817964
9.

Helicobacter pylori eradication for Parkinson's disease.

Rees K, Stowe R, Patel S, Ives N, Breen K, Clarke CE, Ben-Shlomo Y.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD008453. doi: 10.1002/14651858.CD008453.pub2. Review.

PMID:
22071847
10.

Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.

Savarino V, Mela GS, Zentilin P, Lapertosa G, Bisso G, Mele MR, Pivari M, Mansi C, Vigneri S, Celle G.

Ital J Gastroenterol Hepatol. 1999 Jan-Feb;31(1):4-8.

PMID:
10091096
12.
13.

Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.

Fiorini G, Vakil N, Zullo A, Saracino IM, Castelli V, Ricci C, Zaccaro C, Gatta L, Vaira D.

Clin Gastroenterol Hepatol. 2013 May;11(5):507-10. doi: 10.1016/j.cgh.2012.12.007. Epub 2012 Dec 23.

PMID:
23267869
14.
15.

Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.

Sontag SJ, O'Connell S, Schnell T, Chejfec G, Seidel J, Sonnenberg A.

Am J Gastroenterol. 2001 May;96(5):1390-5.

PMID:
11374672
16.

Primary antibiotic resistance and effectiveness of Helicobacter pylori triple therapy in ulcero-inflammatory pathologies of the upper digestive tract.

Aguemon B, Struelens M, Devière J, Denis O, Golstein P, Salmon I, Nagy N.

Acta Gastroenterol Belg. 2005 Jul-Sep;68(3):287-93.

PMID:
16268413
17.

Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.

Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N.

Clin Ther. 2008 Mar;30(3):528-34. doi: 10.1016/j.clinthera.2008.03.009.

PMID:
18405790
18.

Unhealed duodenal ulcers despite Helicobacter pylori eradication.

Gisbert JP, Boixeda D, Martín De Argila C, Alvarez Baleriola I, Abraira V, García Plaza A.

Scand J Gastroenterol. 1997 Jul;32(7):643-50.

PMID:
9246702
19.

Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.

Matsuhisa T, Kawai T, Masaoka T, Suzuki H, Ito M, Kawamura Y, Tokunaga K, Suzuki M, Mine T, Takahashi S, Sakaki N.

Helicobacter. 2006 Jun;11(3):152-8. Erratum in: Helicobacter. 2006 Aug;11(4):306.

PMID:
16684262
20.

Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.

Romano M, Marmo R, Cuomo A, De Simone T, Mucherino C, Iovene MR, Montella F, Tufano MA, Del Vecchio Blanco C, Nardone G.

Clin Gastroenterol Hepatol. 2003 Jul;1(4):273-8.

PMID:
15017668
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk